WUXI BIOLOGICS (CAYMAN) INC.

(2269)
  Rapport
Temps Différé Hong Kong Stock Exchange  -  20/05 10:08:13
56.30 HKD   +7.85%
11/05Les actions de Hong Kong se redressent après avoir atteint leur plus bas niveau depuis près de deux mois ; les actions biotechnologiques sont en hausse.
MT
09/05Création d'un SPAC dédié à la fabrication des produits biopharmaceutiques à Paris
RE
09/05Création d'un SPAC dédié à la fabrication des produits biopharmaceutiques à Paris
RE
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
ETFs positionnés sur WUXI BIOLOGICS (CAYMAN) INC.ETFs et Trackers avec Trackinsight
ETF PoidsVar. 5joursRatingGéographie
UBS ETF Solactive China Technology A-acc ...4.53%3.87%-NC
UBS ETF Solactive China Technology A-acc ...4.53%8.94%-NC
BMO MSCI Genomic Innovation Index ETF - CAD3.81%3.80%-NC
AMUNDI INDEX MSCI EM ASIA SRI PAB - DR (D...3.12%1.64%-NC
Xtrackers FTSE China 50 1C - USD2.97%2.67%Chine
IShares China Large-Cap ETF - USD2.9%6.92%Chine
IShares China Large Cap Acc - USD2.9%1.48%-Chine
IShares China Large Cap Dis - USD2.9%2.54%Chine
BMO MSCI China ESG Leaders Equity Index ET...2.59%4.56%-NC
IShares Dow Jones China Offshore 50 (DE) ...2.39%1.78%Chine
AMUNDI INDEX MSCI EMERGING MARKETS SRI PAB...2.14%1.74%-NC
AMUNDI INDEX MSCI EMERGING MARKETS SRI PAB...2.14%0.83%-NC
IShares MSCI EM SRI - USD2.09%1.39%-NC
IShares MSCI EM SRI - Distributing - USD2.09%1.80%-NC
UBS ETF - MSCI China ESG Universal Low Car...1.98%9.18%-NC
IShares BRIC 50 - USD1.94%2.84%Monde
IShares Core Hang Seng Index ETF - HKD1.92%4.10%-Hong Kong
Deka MSCI China ex A Shares - HKD1.63%1.36%Chine
Xtrackers MSCI China 1C - USD1.4%2.87%Chine
HSBC MSCI CHINA - USD1.36%2.67%Chine
IShares MSCI China - Dist - USD1.35%2.74%-Chine
IShares MSCI China - Accumulating - USD1.35%2.97%-Chine
IShares MSCI China ETF - USD1.34%2.94%-Chine
Franklin FTSE China ETF - USD1.3%5.97%Chine
IShares Asia 50 ETF - USD0.98%1.32%Asie
IShares ESG MSCI EM Leaders ETF Dist - USD0.87%2.03%-NC
IShares MSCI BRIC ETF - USD0.86%4.74%Monde
Desjardins RI Emerging Markets Low CO2 Ind...0.83%0.00%-NC
Invesco MSCI China All Shares Stock Connec...0.72%2.86%-NC
IShares MSCI AC Far East ex-Japan Acc - USD0.55%2.09%-Asie
IShares MSCI AC Far East ex-Japan - USD0.55%1.99%Asie
IShares MSCI EM Asia - USD0.52%1.78%Asie
IShares MSCI All Country Asia ex Japan ETF...0.46%0.00%Asie
Franklin FTSE Asia ex Japan ETF - USD0.44%3.90%Asie
IShares MSCI Emerging Markets ETF - USD0.41%1.69%NC
AMUNDI INDEX MSCI EMERGING MARKETS DR (C)...0.4%0.42%-NC
AMUNDI INDEX MSCI EMERGING MARKETS DR (D)...0.4%0.78%-NC
Amundi Index MSCI Emerging Markets DR - USD0.4%1.93%-NC
Amundi Prime Emerging Markets - DR (C) - USD0.39%1.72%-NC
IShares Global Healthcare ETF - USD0.37%1.86%Monde
UBS (Irl) ETF plc - MSCI Emerging Markets ...0.33%2.23%-NC
UBS ETF (IE) MSCI ACWI Socially Responsibl...0.19%-0.82%-NC
UBS ETF (IE) MSCI ACWI Socially Responsibl...0.19%0.73%-NC
UBS ETF (IE) MSCI ACWI Socially Responsibl...0.19%-0.41%-NC
UBS ETF (IE) MSCI ACWI Socially Responsibl...0.19%-3.21%-NC
UBS (Irl) ETF plc - MSCI ACWI Socially Res...0.19%-3.16%-NC
UBS ETF (IE) MSCI ACWI Socially Responsibl...0.19%3.44%-NC
UBS ETF (IE) MSCI ACWI Socially Responsibl...0.19%0.85%-NC
UBS (Irl) ETF plc - MSCI ACWI Socially Res...0.19%0.42%-NC
IShares MSCI ACWI ex U.S. ETF - USD0.12%3.61%Monde
1  2Suiv.



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Graphique WUXI BIOLOGICS (CAYMAN) INC.
Durée : Période :
WuXi Biologics (Cayman) Inc. : Graphique analyse technique WuXi Biologics (Cayman) Inc. | Zone bourse
Graphique plein écran
Evolution du Compte de Résultat
Consensus
Vente
Achat
Recommandation moyenne ACHETER
Nombre d'Analystes 26
Dernier Cours de Clôture 48,01 CNY
Objectif de cours Moyen 91,42 CNY
Ecart / Objectif Moyen 90,4%
Révisions de BNA
Secteur et Concurrence
Var. 1janvCapi. (M$)
WUXI BIOLOGICS (CAYMAN) INC.-43.60%28 063
CSL LIMITED-5.75%93 171
SAMSUNG BIOLOGICS CO.,LTD.-10.52%44 721
BIOGEN INC.-19.52%28 278
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-25.71%21 889
UCB-11.65%17 758